Literature DB >> 19448666

c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry.

F Morrish1, N Isern, M Sadilek, M Jeffrey, D M Hockenbery.   

Abstract

Cell proliferation requires the coordinated activity of cytosolic and mitochondrial metabolic pathways to provide ATP and building blocks for DNA, RNA and protein synthesis. Many metabolic pathway genes are targets of the c-myc oncogene and cell-cycle regulator. However, the contribution of c-Myc to the activation of cytosolic and mitochondrial metabolic networks during cell-cycle entry is unknown. Here, we report the metabolic fates of [U-(13)C] glucose in serum-stimulated myc(-/-) and myc(+/+) fibroblasts by (13)C isotopomer NMR analysis. We demonstrate that endogenous c-myc increased (13)C labeling of ribose sugars, purines and amino acids, indicating partitioning of glucose carbons into C1/folate and pentose phosphate pathways, and increased tricarboxylic acid cycle turnover at the expense of anaplerotic flux. Myc expression also increased global O-linked N-acetylglucosamine protein modification, and inhibition of hexosamine biosynthesis selectively reduced growth of Myc-expressing cells, suggesting its importance in Myc-induced proliferation. These data reveal a central organizing function for the Myc oncogene in the metabolism of cycling cells. The pervasive deregulation of this oncogene in human cancers may be explained by its function in directing metabolic networks required for cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19448666      PMCID: PMC2779836          DOI: 10.1038/onc.2009.112

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  21 in total

1.  Mitochondrial regulation of cell cycle progression during development as revealed by the tenured mutation in Drosophila.

Authors:  Sudip Mandal; Preeta Guptan; Edward Owusu-Ansah; Utpal Banerjee
Journal:  Dev Cell       Date:  2005-12       Impact factor: 12.270

2.  Perturbations in O-linked beta-N-acetylglucosamine protein modification cause severe defects in mitotic progression and cytokinesis.

Authors:  Chad Slawson; Natasha E Zachara; Keith Vosseller; Win D Cheung; M Daniel Lane; Gerald W Hart
Journal:  J Biol Chem       Date:  2005-07-18       Impact factor: 5.157

3.  Myc influences global chromatin structure.

Authors:  Paul S Knoepfler; Xiao-yong Zhang; Pei Feng Cheng; Philip R Gafken; Steven B McMahon; Robert N Eisenman
Journal:  EMBO J       Date:  2006-05-25       Impact factor: 11.598

4.  The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis.

Authors:  Julian J Lum; Thi Bui; Michaela Gruber; John D Gordan; Ralph J DeBerardinis; Kelly L Covello; M Celeste Simon; Craig B Thompson
Journal:  Genes Dev       Date:  2007-04-16       Impact factor: 11.361

Review 5.  The c-Myc target gene network.

Authors:  Chi V Dang; Kathryn A O'Donnell; Karen I Zeller; Tam Nguyen; Rebecca C Osthus; Feng Li
Journal:  Semin Cancer Biol       Date:  2006-07-25       Impact factor: 15.707

6.  Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis.

Authors:  Feng Li; Yunyue Wang; Karen I Zeller; James J Potter; Diane R Wonsey; Kathryn A O'Donnell; Jung-Whan Kim; Jason T Yustein; Linda A Lee; Chi V Dang
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

7.  Global mapping of c-Myc binding sites and target gene networks in human B cells.

Authors:  Karen I Zeller; XiaoDong Zhao; Charlie W H Lee; Kuo Ping Chiu; Fei Yao; Jason T Yustein; Hong Sain Ooi; Yuriy L Orlov; Atif Shahab; How Choong Yong; Yutao Fu; Zhiping Weng; Vladimir A Kuznetsov; Wing-Kin Sung; Yijun Ruan; Chi V Dang; Chia-Lin Wei
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-08       Impact factor: 11.205

8.  Reversible kinetic analysis of Myc targets in vivo provides novel insights into Myc-mediated tumorigenesis.

Authors:  Elizabeth R Lawlor; Laura Soucek; Lamorna Brown-Swigart; Ksenya Shchors; C Uli Bialucha; Gerard I Evan
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

Review 9.  Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins.

Authors:  Gerald W Hart; Michael P Housley; Chad Slawson
Journal:  Nature       Date:  2007-04-26       Impact factor: 49.962

10.  1H MRS identifies specific metabolite profiles associated with MYCN-amplified and non-amplified tumour subtypes of neuroblastoma cell lines.

Authors:  Andrew C Peet; Carmel McConville; Martin Wilson; Barry A Levine; Michelle Reed; Sara A Dyer; Emma C Edwards; Mary C Strachan; Dominic J McMullan; Timothy M Wilkes; Richard G Grundy
Journal:  NMR Biomed       Date:  2007-11       Impact factor: 4.044

View more
  84 in total

1.  Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP.

Authors:  Liangliang Shen; John M O'Shea; Mohan R Kaadige; Stéphanie Cunha; Blake R Wilde; Adam L Cohen; Alana L Welm; Donald E Ayer
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

2.  CD47 Receptor Globally Regulates Metabolic Pathways That Control Resistance to Ionizing Radiation.

Authors:  Thomas W Miller; David R Soto-Pantoja; Anthony L Schwartz; John M Sipes; William G DeGraff; Lisa A Ridnour; David A Wink; David D Roberts
Journal:  J Biol Chem       Date:  2015-08-26       Impact factor: 5.157

3.  Regulation of Cellular Redox Signaling by Matricellular Proteins in Vascular Biology, Immunology, and Cancer.

Authors:  David D Roberts; Sukhbir Kaur; Jeffrey S Isenberg
Journal:  Antioxid Redox Signal       Date:  2017-09-08       Impact factor: 8.401

Review 4.  Metabolic control of epigenetics in cancer.

Authors:  Adam Kinnaird; Steven Zhao; Kathryn E Wellen; Evangelos D Michelakis
Journal:  Nat Rev Cancer       Date:  2016-09-16       Impact factor: 60.716

5.  18F-fluorodeoxy-glucose positron emission tomography marks MYC-overexpressing human basal-like breast cancers.

Authors:  Nicolaos Palaskas; Steven M Larson; Nikolaus Schultz; Evangelia Komisopoulou; Justin Wong; Dan Rohle; Carl Campos; Nicolas Yannuzzi; Joseph R Osborne; Irina Linkov; Edward R Kastenhuber; Richard Taschereau; Seema B Plaisier; Chris Tran; Adriana Heguy; Hong Wu; Chris Sander; Michael E Phelps; Cameron Brennan; Elisa Port; Jason T Huse; Thomas G Graeber; Ingo K Mellinghoff
Journal:  Cancer Res       Date:  2011-06-06       Impact factor: 12.701

Review 6.  Metabolic effects of signal transduction inhibition in cancer assessed by magnetic resonance spectroscopy.

Authors:  Siver Andreas Moestue; Olav Engebraaten; Ingrid Susann Gribbestad
Journal:  Mol Oncol       Date:  2011-04-23       Impact factor: 6.603

Review 7.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

8.  Hyaluronan Production Regulates Metabolic and Cancer Stem-like Properties of Breast Cancer Cells via Hexosamine Biosynthetic Pathway-coupled HIF-1 Signaling.

Authors:  Theerawut Chanmee; Pawared Ontong; Tomomi Izumikawa; Miho Higashide; Nobutoshi Mochizuki; Chatchadawalai Chokchaitaweesuk; Manatsanan Khansai; Kazuki Nakajima; Ikuko Kakizaki; Prachya Kongtawelert; Naoyuki Taniguchi; Naoki Itano
Journal:  J Biol Chem       Date:  2016-10-06       Impact factor: 5.157

Review 9.  The role of supercoiling in transcriptional control of MYC and its importance in molecular therapeutics.

Authors:  Tracy A Brooks; Laurence H Hurley
Journal:  Nat Rev Cancer       Date:  2009-11-12       Impact factor: 60.716

Review 10.  Rethinking the Warburg effect with Myc micromanaging glutamine metabolism.

Authors:  Chi V Dang
Journal:  Cancer Res       Date:  2010-01-19       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.